All stock lists
BridgeBio Oncology Therapeutics, Inc. (NASDAQ:BBOT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.64-0.02 (-0.75%)
Insider Score
––Not scored
BBOT Insider Score
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BBOT Stock Insider Trading Activity
BBOT stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Cobo Marc Other | Tax withheld | 203 | $2.68 | $544.04 | 1.4% | 13,812 | Oct 21, 2026 | — | Form 4 |
| Elmelech Idan COO | Tax withheld | 343 | $3.94 | $1.35K | 2.4% | 14,152 | Oct 1, 2026 | — | Form 4 |
| Cobo Marc Other | Tax withheld | 126 | $3.94 | $496.44 | 0.9% | 14,015 | Oct 1, 2026 | — | Form 4 |
| Ben Yong Other | Tax withheld | 1,047 | $3.94 | $4.13K | 2.3% | 43,529 | Oct 1, 2026 | — | Form 4 |
| Beltran Pedro CEO | Tax withheld | 1,047 | $3.94 | $4.13K | 2.3% | 43,529 | Oct 1, 2026 | — | Form 4 |
| Cobo Marc Other | Award | 9,038 | — | — | 170% | 14,344 | Sep 10, 2026 | — | Form 4 |
| Cobo Marc Other | Tax withheld | 203 | $5.52 | $1.12K | 1.4% | 14,141 | Sep 10, 2026 | — | Form 4 |
| Elmelech Idan COO | Tax withheld | 343 | $7.80 | $2.68K | 2.3% | 14,495 | Jul 1, 2026 | — | Form 4 |
| Cobo Marc Other | Tax withheld | 125 | $7.80 | $975 | 2.3% | 5,306 | Jul 1, 2026 | — | Form 4 |
| Ben Yong Other | Tax withheld | 1,047 | $7.80 | $8.17K | 2.3% | 44,576 | Jul 1, 2026 | — | Form 4 |
| Beltran Pedro CEO | Tax withheld | 1,047 | $7.80 | $8.17K | 2.3% | 44,576 | Jul 1, 2026 | — | Form 4 |
| Chen Bihua Director | Other | 2,692,459 | — | — | 123% | 4,879,995 | Jul 1, 2026 | — | Form 4 |
| Chen Bihua Director | Other | 1,704,862 | — | — | 51.6% | 5,010,332 | Jul 1, 2026 | — | Form 4 |
| Chen Bihua Director | Other | 130,865 | — | — | 2.2% | 6,083,221 | Jul 1, 2026 | — | Form 4 |
| Chen Bihua Director | Other | 4,528,186 | — | — | 100% | 0 | Jul 1, 2026 | — | Form 4 |
| Mehra Uneek Other | Tax withheld | 524 | $9.03 | $4.73K | 2.2% | 22,806 | Apr 1, 2026 | — | Form 4 |
| Ben Yong Other | Tax withheld | 1,047 | $9.03 | $9.45K | 2.2% | 45,623 | Apr 1, 2026 | — | Form 4 |
| Beltran Pedro CEO | Tax withheld | 1,047 | $9.03 | $9.45K | 2.2% | 45,623 | Apr 1, 2026 | — | Form 4 |
| Beltran Pedro Other | Award | 46,670 | — | — | New | 46,670 | Mar 10, 2026 | — | Form 4 |
| Mehra Uneek CFO | Award | 23,330 | — | — | New | 23,330 | Mar 10, 2026 | — | Form 4 |
| Ben Yong Other | Award | 46,670 | — | — | New | 46,670 | Mar 10, 2026 | — | Form 4 |
| BridgeBio Pharma LLC Other | Other | 784,720 | — | — | 5.7% | 14,589,846 | Oct 10, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Award (A) — Grant or award from the company, not a purchase
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Other (J) — Other acquisition or disposition — the filing explains it in a footnote
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.